Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Film Coated Tablets 28 X 14 mg |
|
37647 | 24547 |
Related information
Dosage
The recommended dose of teriflunomide is 14 mg once daily.
Indications
Treatment of adults with relapsing-remitting multiple sclerosis, in order to reduce the frequency of relapses and to delay the progression of physical disability.
Contra-Indications
* Hypersensitivity to the active substance or to any of the excipients.
* Patients with severe hepatic impairment (Child-Pugh class C).
* Pregnant women, or women of childbearing potential, breast-feeding.
* Patients with severe immunodeficiency states, e.g. acquired immunodeficiency syndrome (AIDS).
* Patients with significantly impaired bone marrow function or significant anaemia, leukopenia, neutropenia or thrombocytopenia.
* Patients with severe active infection until resolution.
* Patients with severe renal impairment undergoing dialysis, because insufficient clinical experience is available in this patient group. Patients with severe hypoproteinaemia, e.g. in nephrotic syndrome.
Special Precautions
Please refer to the license holder for further details.
Side Effects
Please refer to the license holder for further details.
Drug interactions
Please refer to the license holder for further details.
Pregnancy and Lactation
Please refer to the license holder for further details.
Overdose
Please refer to the license holder for further details.
